Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout

References

• Arie E., Doherty M. Crystal associated rheumatic disease: current management considerations. Drugs 1989; 37: 566–5761. Arie E., Doherty M. Crystal associated rheumatic disease: current management considerations. Drugs 1989; 37: 566–576
   PubMed Web of Science ®Google Scholar
• Bacon P. A. An overview of the efficacy of etodolac in arthritic disorders. Eur. J. Rheumatol. Inflamm. 1990; 10: 22–342. Bacon P. A. An overview of the efficacy of etodolac in arthritic disorders. Eur. J. Rheumatol. Inflamm. 1990; 10: 22–34
   PubMedGoogle Scholar
• Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 1979; 18: 241–2773. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 1979; 18: 241–277
   PubMed Web of Science ®Google Scholar
• Gaston G. N., Mallow R. D., Frank J. E. The efficacy of etodolac compared with aspirin and placebo in patients with pain following oral surgery. J. Oral Maxillofac. Surg. 1989; 42: 362–3664. Gaston G. N., Mallow R. D., Frank J. E. The efficacy of etodolac compared with aspirin and placebo in patients with pain following oral surgery. J. Oral Maxillofac. Surg. 1989; 42: 362–366
   Google Scholar
• Jacob G. B., Hart K. K., Mullane J. R., Lutins S., Lee T. Y. Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. Curr. Ther. Res. 1983; 33: 703–7135. Jacob G. B., Hart K. K., Mullane J. R., Lutins S., Lee T. Y. Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. Curr. Ther. Res. 1983; 33: 703–713
   Web of Science ®Google Scholar
• Jacob G., Sanda M., Mullane J., Kennedy J., Barbetti M., Suleski P. Long-term evaluation of the efficacy and safety of etodolac in the treatment of rheumatoid arthritis. Adv. Ther. 1985; 2: 82–956. Jacob G., Sanda M., Mullane J., Kennedy J., Barbetti M., Suleski P. Long-term evaluation of the efficacy and safety of etodolac in the treatment of rheumatoid arthritis. Adv. Ther. 1985; 2: 82–95
   Google Scholar
• Jahss M. H. Disorders of the Foot. Saunders, Philadelphia 1982; 1014–10237. Jahss M. H. Disorders of the Foot. Saunders, Philadelphia 1982; 1014–1023
   Google Scholar
• Landry J. R., Schilero J. The medical/surgical management of gout. J. Foot Surg. 1986; 25: 160–1758. Landry J. R., Schilero J. The medical/surgical management of gout. J. Foot Surg. 1986; 25: 160–175
   PubMedGoogle Scholar
• Lederman R. A double-blind comparison of etodolac (Lodine®) and high doses of naproxen in the treatment of acute gout. Adv. Ther. 1990; 7: 344–3549. Lederman R. A double-blind comparison of etodolac (Lodine®) and high doses of naproxen in the treatment of acute gout. Adv. Ther. 1990; 7: 344–354
   Google Scholar
• Marino C. T., Greenwald R. A. Acute arthritis. Med. Clin. North Am. 1981; 65: 17710. Marino C. T., Greenwald R. A. Acute arthritis. Med. Clin. North Am. 1981; 65: 177
   PubMed Web of Science ®Google Scholar
• Mizraji M. Clinical response to etodolac in the management of pain. Eur. J. Rheumatol. Inflamm. 1990; 10: 35–4311. Mizraji M. Clinical response to etodolac in the management of pain. Eur. J. Rheumatol. Inflamm. 1990; 10: 35–43
   PubMedGoogle Scholar
• Nelson S. L., Bergman S. A. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth. Prog. July/Aug., 1985; 151–15612. Nelson S. L., Bergman S. A. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin, and placebo. Anesth. Prog. July/Aug., 1985; 151–156
   PubMedGoogle Scholar
• Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol. Int. 1991; 17: 1–1413. Pena M. Etodolac: analgesic effects in musculoskeletal and postoperative pain. Rheumatol. Int. 1991; 17: 1–14
   Google Scholar
• Reginato A. J., Schumacher H. R., Jr. Crystal-associated arthropathies. Clin. Geriatr. Med. 1988; 4: 295–32214. Reginato A. J., Schumacher H. R., Jr. Crystal-associated arthropathies. Clin. Geriatr. Med. 1988; 4: 295–322
   PubMedGoogle Scholar
• Primer on the Rheumatic Diseases7th edit., G. P. Rodman. Arthritis Foundation, Atlanta 1973; 95–10415. Primer on the Rheumatic Diseases7th edit., G. P. Rodman. Arthritis Foundation, Atlanta 1973; 95–104
   Google Scholar
• Sanda M., Collins S. H., Mahady J., Huth J., Krantz K. Three-month multicenter study of etodolac (Ultradol®) in patients with osteoarthritis of the hip. Curr. Then Res. 1983; 33: 782–79216. Sanda M., Collins S. H., Mahady J., Huth J., Krantz K. Three-month multicenter study of etodolac (Ultradol®) in patients with osteoarthritis of the hip. Curr. Then Res. 1983; 33: 782–792
   Web of Science ®Google Scholar
• Semi U. Global safety of etodolac: reports from worldwide postmarketing surveillance studies. Rheumatol. Intl. 1990; 10: 1–3417. Semi U. Global safety of etodolac: reports from worldwide postmarketing surveillance studies. Rheumatol. Intl. 1990; 10: 1–34
   Google Scholar
• Sloan R. W. Hyperuricemia and gout. J. Fam. Pract. 1982; 14: 92318. Sloan R. W. Hyperuricemia and gout. J. Fam. Pract. 1982; 14: 923
   PubMed Web of Science ®Google Scholar
• Wallace S. Colchicine. Semin. Arthritis Rheum. 1974; 3: 369–38119. Wallace S. Colchicine. Semin. Arthritis Rheum. 1974; 3: 369–381
   PubMedGoogle Scholar
• Wallace S. L., Singer J. Z. Review: Systemic toxicity associated with the intravenous administration of colchicine – guidelines for use. J. Rheumatol. 1988; 15: 495–49920. Wallace S. L., Singer J. Z. Review: Systemic toxicity associated with the intravenous administration of colchicine – guidelines for use. J. Rheumatol. 1988; 15: 495–499
   PubMed Web of Science ®Google Scholar
• Wallace S. L., Singer J. Z. Therapy in gout. Rheum. Dis. Clin. North Am. 1988; 14: 441–45721. Wallace S. L., Singer J. Z. Therapy in gout. Rheum. Dis. Clin. North Am. 1988; 14: 441–457
   PubMed Web of Science ®Google Scholar
• Zvaifler N. A review of the antiarthritic safety and efficacy of etodolac. Clin. Rheumatol. 1989; 8(Suppl. 1)45–5322. Zvaifler N. A review of the antiarthritic safety and efficacy of etodolac. Clin. Rheumatol. 1989; 8(Suppl. 1)45–53
   Google Scholar